Sort
16,179 grants matching “malaria”
Rapid Point-of-Care RNA Diagnostic for Dengue Infection
$999,799Hyundae Cho · Crosslife Technologies, Inc. · R44 · FY2021 · AI
Rapid Point-of-Care RNA Diagnostic for Dengue Infection
$999,799Hyundae Cho · Crosslife Technologies, Inc. · R44 · FY2022 · AI
Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine
$999,762Christopher Locher · Versatope Therapeutics, Inc. · R44 · FY2024 · AI
Preclinical development of novel small molecule malaria drugs that overcome drug
$999,700David H Peyton · Designmedix, Inc. · R42 · FY2015 · AI
Babesia antigen detection assay for blood screening
$999,660Andrew E. Levin · Immunetics, Inc. · R44 · FY2015 · HL
PfSPZ Vaccine for Malaria: Towards a Successful Biologics License Application and Commercialization
$999,570Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2021 · AI
Development of peptide nucleic acid antibiotics
$999,557Dev Priya Arya · Nubad, Llc · R42 · FY2023 · AI
Progressing PfSPZ vaccines for malaria to licensure and commercialization
$999,345Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2024 · AI
Genomic Studies of the Impact of External Factors on Parasite Development and Disease Outcome
$999,314Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2020 · AI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine
$999,306Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2022 · AI
Determinants of Malaria Disease in Malawi
$999,292Terrie Ellen Taylor · Michigan State University · U19 · FY2010 · AI
Mali International Center for Excellence in Research: Parasitic Infectious Diseases and their Vectors
$999,237Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Malarial retinopathy screening system for improved diagnosis of cerebral malaria
$999,158Vinayak S Joshi · Visionquest Biomedical Inc · SB1 · FY2021 · AI
A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage
$999,150B. Kim Lee Sim · Sanaria, Inc. · R44 · FY2025 · AI
AWI-Gen Phase 2: Genomic and environmental risk factors for cardiometabolic disease in Africans
$999,112Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2019 · HG
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites
$999,025Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2020 · AI
A modular platform for infectious disease surveillance at point-of-need.
$998,995Jay Kenneth Fisher · Redbud Labs, Inc. · R44 · FY2022 · AI
A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage
$998,971B. Kim Lee Sim · Sanaria, Inc. · R44 · FY2024 · AI
PfSPZ Vaccine for Malaria: Towards a Successful Biologics License Application and Commercialization
$998,833Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2020 · AI
Immune Deficient Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture
$998,817Peter F. Billingsley · Sanaria, Inc. · R44 · FY2017 · AI
Development of peptide nucleic acid antibiotics
$998,585Dev Priya Arya · Nubad, Llc · R42 · FY2024 · AI
After the flood: Optimal strategies to prevent malaria epidemics caused by severe flooding
$997,980Ross Mathew Boyce · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$997,637Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2017 · AI
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$997,404Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2020 · AI
The BLOODSAFE Data Coordinating Center: A Data Center for More SafeTransfusions in Sub-Saharan Africa
$997,256Cavan S. Reilly · University Of Minnesota · U24 · FY2025 · HL